Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
HeartBeam, Inc.
BEAT
NASDAQ·Healthcare·Medical - Equipment & Services·Mkt cap $25.1M
$0.72
▼ -1.28%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$0.54 - $4.00
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 44.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary miniaturized ECG technology in credit card form factor
- Integrated cloud-based diagnostic platform with AI-powered analysis
- Strategic positioning in high-growth remote patient monitoring market
- Patent-protected innovations in cardiac detection and telehealth
Bear Case
1 risk
- Low volatility (beta -0.9).
Growth
Revenue decline expected
Rising adoption of remote patient monitoring and telehealth solutions
Value
Deep value opportunity - significant discount to Healthcare IT & Services peers
Momentum
Falling
-39.0% over 3m
Quality
Loss-making
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying BEAT right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Aug 6, 2026
MAY 13, 2026
Reported EPS of -$0.12 vs -$0.14 consensus (+14.3% surprise).
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+14.3%
Next: Aug 6, 2026
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$0
$0
$0
$0
$0
$0
$0
$0
Margins · last 8Q
No margin history available.
Wall Street consensus
3 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · May 22, 2026